Tevogen Bio Holdings (FRA:G280) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:G280 Tevogen Bio Holdings Inc FRA:G280
10 GF Score
Price €7.70
! 4 Warning Signs
View Full Analysis

What is Tevogen Bio Holdings FFO?

FFO (Funds from operations) only applies to REITs.

FRA:G280
10GF Score
Tevogen Bio Holdings Inc FRA:G280
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tevogen Bio Holdings Business Description

Other Exchanges TVGN:USA
Address 15 Independence Boulevard, Suite 210, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
10GF Score

Get the complete analysis for FRA:G280

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.70
Price